BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3281200)

  • 1. Morphologic diagnosis of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Semin Diagn Pathol; 1988 Feb; 5(1):104-21. PubMed ID: 3281200
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathology of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):759-71. PubMed ID: 3291311
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
    Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 5. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity.
    Solez K; McGraw DJ; Beschorner WE; Kone BC; Racusen LC; Whelton A; Burdick JF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):123-33. PubMed ID: 3927535
    [No Abstract]   [Full Text] [Related]  

  • 9. Histopathology of cyclosporine.
    Wallace AC
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):117-22. PubMed ID: 3895653
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
    Shen SY; Wood C; Amin AN; Papadimitriou JC; Weir MR; Coughlin TR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1508-10. PubMed ID: 2652486
    [No Abstract]   [Full Text] [Related]  

  • 12. Five-year serial renal graft biopsy study in cyclosporine-treated patients.
    Wilczek H; Bohman SO; Klintmalm G; Groth CG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):812-5. PubMed ID: 3291319
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Adv Nephrol Necker Hosp; 1988; 17():303-20. PubMed ID: 3124545
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity.
    te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL
    Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against chronic progressive cyclosporine nephrotoxicity.
    Ben-Maimon CS; Burke JF; Besarab A; Jarrell BE; Francos GC; Moyer SS
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1260-2. PubMed ID: 1989206
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biopsy findings in kidney transplants after treatment with cyclosporin A].
    Nizze H; Gokel JM; Lang W; Mihatsch MJ
    Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
    Barrett M; Milton AD; Barrett J; Taube D; Bewick M; Parsons VP; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1769-71. PubMed ID: 3152634
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine. Problems in differential diagnosis--drug toxicity versus allograft rejection.
    Transplant Proc; 1983 Dec; 15(4 Suppl 1-2):2813-54. PubMed ID: 6364509
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.